Immunohistochemistry Digital Breast Cancer Panel 3 Test sale cost 1000 AED
PML RARA t1517q22q12 Gene Rearrangement Quantitative MRD Monitor Test sale cost 1220 AED PML RARA t1517q22q12 Gene Rearrangement Quantitative MRD Monitor Test Cost 1,350 د.إ Original price was: 1,350 د.إ.1,220 د.إCurrent price is: 1,220 د.إ.
T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test sale cost 1170 AED T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test Cost 1,300 د.إ Original price was: 1,300 د.إ.1,170 د.إCurrent price is: 1,170 د.إ.
Sale!

Immunohistochemistry Digital Breast Cancer Panel 3 Test Cost

Original price was: 1,300 د.إ.Current price is: 1,000 د.إ.

-23%

The Immunohistochemistry Digital Breast Cancer Panel 3 Test is a sophisticated diagnostic tool used to aid in the detection and characterization of breast cancer. This test is performed at DNA Labs UAE, a reputable facility known for its cutting-edge technology and expert medical staff. Priced at 1000 AED, this test utilizes immunohistochemistry (IHC) techniques to identify specific proteins and markers on the surface of cells in breast tissue samples. These markers can provide valuable information about the type of breast cancer, its aggressiveness, and potential response to treatment. By employing digital imaging technology, the test ensures highly accurate and detailed analysis, enabling personalized treatment plans for patients. This test is essential for oncologists and patients alike, offering insights that can significantly impact treatment decisions and outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 Test

At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test for the evaluation of breast cancer. This diagnostic tool is an immunohistochemistry (IHC) panel that consists of specific antibodies targeting different proteins expressed in breast cancer cells.

Test Components

  • ER (Estrogen Receptor)
  • PR (Progesterone Receptor)
  • HER-2 (Human Epidermal Growth Factor Receptor 2)
  • Photomicrograph
  • Includes Pathologist review for presence of malignant cells

Test Cost

The cost of the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is AED 1000.0.

Symptoms and Diagnosis

If you are experiencing symptoms of breast cancer or have received a positive diagnosis, the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test can provide valuable information for your treatment plan.

Sample Condition

To ensure accurate results, please submit tumour tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. The sample should be shipped at room temperature. Additionally, provide a copy of the Histopathology report, indicate the site of biopsy, and provide clinical history.

Report Delivery

Sample Daily by 6 pm

  • Report – Block: 5 days
  • Tissue Biopsy: 5 days
  • Tissue Large Complex: 7 days

Method

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is performed using immunohistochemistry, a technique that involves staining breast tissue samples with specific antibodies. The stained samples are then examined under a microscope to determine the presence and intensity of ER, PR, and HER2 expression in the tumor cells.

Test Type

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is classified as a cancer test.

Doctor

This test is typically ordered by an oncologist.

Test Department

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is conducted in the Histology department at DNA Labs UAE.

Pre Test Information

Prior to the test, please provide a copy of the Histopathology report, indicate the site of biopsy, and provide clinical history.

Test Details

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is a valuable tool in the evaluation of breast cancer. It helps determine the subtype of breast cancer and guides treatment decisions. The panel includes antibodies against estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These markers are crucial in determining the appropriate use of hormonal therapy and targeted therapies, as well as prognosis and overall patient management.

The ER and PR markers indicate whether the cancer cells are responsive to hormonal therapies such as tamoxifen or aromatase inhibitors. The HER2 marker is overexpressed in some breast cancers and helps determine eligibility for targeted therapies like trastuzumab.

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test involves staining breast tissue samples with specific antibodies and examining them under a microscope. The results provide information about the presence and intensity of ER, PR, and HER2 expression in the tumor cells.

If you are in need of the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test, contact DNA Labs UAE today to schedule an appointment with an oncologist.

Test Name IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 Test
Components *ER *PR *HER-2 *Photomicrograph *Includes Pathologist review for presence of malignant cells
Price 1000.0 AED
Sample Condition Submit tumour tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report. Indicate site of biopsy and provide Clinical history.
Report Delivery Sample Daily by 6 pm; Report – Block: 5 days Tissue Biopsy: 5 days Tissue Large Complex: 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report. Indicate site of biopsy and provide Clinical history.
Test Details

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test is a diagnostic tool used in the evaluation of breast cancer. It is an immunohistochemistry (IHC) panel that consists of specific antibodies targeting different proteins expressed in breast cancer cells.

The panel includes antibodies against estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These markers are important in determining the subtype of breast cancer and guiding treatment decisions.

The ER and PR markers are hormone receptors that indicate whether the cancer cells are responsive to hormonal therapies such as tamoxifen or aromatase inhibitors. HER2 is a growth factor receptor that is overexpressed in some breast cancers, and its status helps determine eligibility for targeted therapies like trastuzumab.

The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 3 test involves staining breast tissue samples with these antibodies and then examining them under a microscope. The results of the test provide information about the presence and intensity of ER, PR, and HER2 expression in the tumor cells.

This panel is commonly used in the clinical management of breast cancer patients to guide treatment decisions. It helps determine the appropriate use of hormonal therapy and targeted therapies, as well as prognosis and overall patient management.

SKU: TEST-5675 Category:

Related products